Literature DB >> 29378336

Modulation of the rod outer segment aerobic metabolism diminishes the production of radicals due to light absorption.

Daniela Calzia1, Paolo Degan2, Federico Caicci3, Maurizio Bruschi4, Lucia Manni3, Luca A Ramenghi5, Giovanni Candiano5, Carlo Enrico Traverso6, Isabella Panfoli7.   

Abstract

Oxidative stress is a primary risk factor for both inflammatory and degenerative retinopathies. Our previous data on blue light-irradiated retinas demonstrated an oxidative stress higher in the rod outer segment (OS) than in the inner limb, leading to impairment of the rod OS extra-mitochondrial aerobic metabolism. Here the oxidative metabolism and Reactive Oxygen Intermediates (ROI) production was evaluated in purified bovine rod OS in function of exposure to different illumination conditions. A dose response was observed to varying light intensities and duration in terms of both ROI production and ATP synthesis. Pretreatment with resveratrol, inhibitor of F1Fo-ATP synthase, or metformin, inhibitor of the respiratory complex I, significantly diminished the ROI production. Metformin also diminished the rod OS Complex I activity and reduced the maximal OS response to light in ATP production. Data show for the first time the relationship existing in the rod OS between its -aerobic- metabolism, light absorption, and ROI production. A beneficial effect was exerted by metformin and resveratrol, in modulating the ROI production in the illuminated rod OS, suggestive of their beneficial action also in vivo. Data shed new light on preventative interventions for cone loss secondary to rod damage due to oxidative stress.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATP synthase; Diabetic dim light; Light; Metformin; Oxidative stress; Reactive oxygen intermediates; Resveratrol; Rod outer segment

Mesh:

Substances:

Year:  2018        PMID: 29378336     DOI: 10.1016/j.freeradbiomed.2018.01.029

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

1.  Retinal neovascularization induced by mutant Vldlr gene inhibited in an inherited retinitis pigmentosa mouse model: an in-vivo study.

Authors:  Wei-Ming Yan; Pan Long; Mei-Zhu Chen; Dong-Yu Wei; Jian-Cong Wang; Zuo-Ming Zhang; Lei Zhang; Tao Chen
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

2.  Preventive Effects against Retinal Degeneration by Centella asiatica Extract (CA-HE50) and Asiaticoside through Apoptosis Suppression by the Nrf2/HO-1 Signaling Pathway.

Authors:  Dae-Won Park; Yeong-Geun Lee; Yong-Joon Jeong; Hyelin Jeon; Se-Chan Kang
Journal:  Antioxidants (Basel)       Date:  2021-04-16

3.  Beneficial effect of polyphenols in COVID-19 and the ectopic F1 FO -ATP synthase: Is there a link?

Authors:  Isabella Panfoli; Alfonso Esposito
Journal:  J Cell Biochem       Date:  2022-07-15       Impact factor: 4.480

4.  The Flavone Cirsiliol from Salvia x jamensis Binds the F1 Moiety of ATP Synthase, Modulating Free Radical Production.

Authors:  Lavinia Carlini; Gabriele Tancreda; Valeria Iobbi; Federico Caicci; Silvia Bruno; Alfonso Esposito; Daniela Calzia; Stefano Benini; Angela Bisio; Lucia Manni; Anna Schito; Carlo Enrico Traverso; Silvia Ravera; Isabella Panfoli
Journal:  Cells       Date:  2022-10-09       Impact factor: 7.666

5.  Differential expression of the five redox complexes in the retinal mitochondria or rod outer segment disks is consistent with their different functionality.

Authors:  Maurizio Bruschi; Martina Bartolucci; Andrea Petretto; Daniela Calzia; Federico Caicci; Lucia Manni; Carlo Enrico Traverso; Giovanni Candiano; Isabella Panfoli
Journal:  FASEB Bioadv       Date:  2020-03-31

Review 6.  Targeting Neurovascular Interaction in Retinal Disorders.

Authors:  Zhongjie Fu; Ye Sun; Bertan Cakir; Yohei Tomita; Shuo Huang; Zhongxiao Wang; Chi-Hsiu Liu; Steve S Cho; William Britton; Timothy S Kern; David A Antonetti; Ann Hellström; Lois E H Smith
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.